Osterweis Capital Management Inc. trimmed its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,991 shares of the company’s stock after selling 130 shares during the quarter. Osterweis Capital Management Inc.’s holdings in […]